Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
15.67
+0.50 (3.30%)
Jul 28, 2026, 12:15 PM EDT - Market open

Surgery Partners Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,3443,3093,1142,7432,5392,225
Revenue Growth
5.38%6.24%13.52%8.03%14.12%19.62%
Gross Profit
763.3765745.6647.5574.9491.4
Operating Income
393.4389.5348.8328345.2302.2
Net Income
-76.1-77.9-168.1-11.9-54.6-152.1
Earnings Per Share
-0.60-0.61-1.33-0.09-0.59-1.12
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Private Insurance
1,6801,6871,6341,4191,2881,110
Government
1,4221,3801,2571,1281,059949.9
Self-Pay
8787.682.368.165.961.1
Other Patient Service
71.871.281.185.68973.9
Other Service
83.682.459.942.937.230.1
Revenue (Total)
3,3443,3093,1142,7432,5392,225

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
182.3239.9269.5195.9282.9389.9
Total Debt
3,9863,9823,6623,0242,8933,254
Net Cash (Debt)
-3,804-3,742-3,393-2,828-2,610-2,865
Net Cash Growth
------
Net Cash Per Share
-29.80-29.42-26.90-22.51-28.39-39.55

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
280274.3300.1293.8158.887.1
Capital Expenditures
-72-78.7-90.4-88.8-80.6-57.6
Free Cash Flow
208195.6209.720578.229.5
Free Cash Flow Growth
20.02%-6.72%2.29%162.15%165.08%-85.54%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
22.83%23.12%23.94%23.60%22.64%22.08%
Operating Margin
11.77%11.77%11.20%11.96%13.59%13.58%
Pretax Margin
3.41%3.53%4.72%4.92%4.34%3.65%
Profit Margin
2.90%2.99%0.40%4.93%3.43%3.18%
FCF Margin
6.22%5.91%6.73%7.47%3.08%1.33%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
31.9124.9323.3135.0858.71183.86
P/FCF Ratio
9.4510.2112.8319.7544.88161.74
PS Ratio
0.590.600.861.481.382.14